Medtronic (MDT) Capital Expenditures Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -6.72% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 15.89% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -47.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -11.95% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -43.42% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 27.22% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -18.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 23, 2026 | -6.72% |
| Oct 24, 2025 | 15.84% |
| Jul 25, 2025 | -3.08% |
| Apr 25, 2025 | 7.75% |
| Jan 24, 2025 | 37.57% |
| Oct 25, 2024 | -12.36% |
| Jul 26, 2024 | 46.89% |
| Apr 26, 2024 | 12.70% |
| Jan 26, 2024 | 4.22% |
| Oct 27, 2023 | 42.72% |
| Jul 28, 2023 | -16.90% |
| Apr 28, 2023 | -2.83% |
| Jan 27, 2023 | 0.61% |
| Oct 28, 2022 | 19.19% |
| Jul 29, 2022 | 12.70% |
| Apr 29, 2022 | 3.18% |
| Jan 28, 2022 | -9.09% |
| Oct 29, 2021 | -3.56% |
| Jul 30, 2021 | 13.17% |
| Apr 30, 2021 | 12.20% |
| Jan 29, 2021 | 23.89% |
| Oct 30, 2020 | -0.71% |
| Jul 31, 2020 | 10.96% |
| Apr 24, 2020 | 0.30% |
| Jan 24, 2020 | -2.98% |
| Oct 25, 2019 | 37.38% |
| Jul 26, 2019 | 3.44% |
| Apr 26, 2019 | 14.73% |
| Jan 25, 2019 | 19.84% |
| Oct 26, 2018 | -16.26% |
| Jul 27, 2018 | 4.68% |
| Apr 27, 2018 | -11.52% |
| Jan 26, 2018 | -22.70% |
| Oct 27, 2017 | -8.21% |
| Jul 28, 2017 | -15.76% |
| Apr 28, 2017 | -6.52% |
| Jan 27, 2017 | 31.98% |
| Oct 28, 2016 | 20.72% |
| Jul 29, 2016 | 47.32% |
| Apr 29, 2016 | 38.43% |
| Jan 29, 2016 | 133.02% |
| Oct 30, 2015 | 119.80% |
| Jul 31, 2015 | 105.50% |